Breast Cancer: From Precision Medicine to Diagnostics
A special issue of Bioengineering (ISSN 2306-5354). This special issue belongs to the section "Biomedical Engineering and Biomaterials".
Deadline for manuscript submissions: 30 September 2025 | Viewed by 935
Special Issue Editor
Special Issue Information
Dear Colleagues,
Breast cancer is a complex and heterogeneous disease that affects millions of women worldwide. In recent years, significant advancements have been made in the fields of precision medicine, diagnostics, and novel treatment options for patients with breast cancer. Precision medicine allows for more personalized and targeted treatment strategies based on an individual's unique genetic makeup, helping to improve patient outcomes and reduce the risk of recurrence. Diagnostic tools, such as genetic testing and imaging techniques, have also evolved to provide more accurate and early detection of breast cancer, leading to better prognosis and survival rates.
Novel treatment options, such as immunotherapy and targeted therapies, are revolutionizing the way breast cancer is treated, offering more effective and less toxic alternatives to traditional chemotherapy. These innovative approaches are paving the way for more personalized and tailored treatment plans for patients with breast cancer, ultimately improving survival rates and patients’ quality of life. In this era of rapid advancements in breast cancer research, it is crucial to continue exploring new avenues in precision medicine, diagnostics, and treatment options to further improve outcomes for patients battling this devastating disease.
Dr. Kosuke Kawaguchi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- precision medicine
- diagnostics
- novel treatment options
- personalized treatment
- tumor microenvironment
- breast imaging
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.